Literature DB >> 4277731

The tolerance of high dose intravenous spectinomycin therapy in man.

E Novak, C A Schlagel, L A LeZotte, R T Pfeifer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4277731     DOI： 10.1002/j.1552-4604.1974.tb02326.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN： 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  9 in total

1.  Structure-Activity Relationships of Spectinamide Antituberculosis Agents: A Dissection of Ribosomal Inhibition and Native Efflux Avoidance Contributions.

Authors:  Jiuyu Liu; David F Bruhn; Robin B Lee; Zhong Zheng; Tanja Janusic; Dimitri Scherbakov; Michael S Scherman; Helena I Boshoff; Sourav Das; Samanthi L Waidyarachchi; Tiffany A Brewer; Begoña Gracia; Lei Yang; John Bollinger; Gregory T Robertson; Bernd Meibohm; Anne J Lenaerts; Jose Ainsa; Erik C Böttger; Richard E Lee
Journal:  ACS Infect Dis       Date:  2016-11-11       Impact factor: 5.084

2.  In vitro antibacterial activity of trospectomycin (U-63366F), a novel spectinomycin analog.

Authors:  G E Zurenko; B H Yagi; J J Vavra; B B Wentworth
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

3.  Human safety and pharmacokinetics of a single intramuscular dose of a novel spectinomycin analog, trospectomycin (U-63,366F).

Authors:  E Novak; L M Paxton; A Bye; R Patel; G E Zurenko; S F Francom
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

4.  Derivatives of 4-dihydro-4-deoxy-4(R)-amino spectinomycin and their activity against susceptible and resistant Escherichia coli strains.

Authors:  R G Werner; U L Lechner; H Goeth
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

5.  In vitro activity of spectinomycin against recent urinary tract isolates.

Authors:  R J Fass; R B Prior
Journal:  Antimicrob Agents Chemother       Date:  1977-10       Impact factor: 5.191

6.  In vitro activity of trospectomycin (U-63366F), a novel spectinomycin analog, against gram-positive isolates from cancer patients.

Authors:  K Rolston; D H Ho; G P Bodey
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-03       Impact factor: 3.267

7.  SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis.

Authors:  Jiyu Zhou; Shuang Cui; Qingxian He; Yitong Guo; Xiaojie Pan; Pengfei Zhang; Ningning Huang; Chaoliang Ge; Guangji Wang; Frank J Gonzalez; Hong Wang; Haiping Hao
Journal:  Nat Commun       Date:  2020-01-13       Impact factor: 14.919

Review 8.  Bioanalysis of aminoglycosides using high-performance liquid chromatography.

Authors:  Seth K Amponsah; Joseph A Boadu; Daniel K Dwamena; Kwabena F M Opuni
Journal:  ADMET DMPK       Date:  2022-02-14

9.  Spectinamides: a new class of semisynthetic antituberculosis agents that overcome native drug efflux.

Authors:  Richard E Lee; Julian G Hurdle; Jiuyu Liu; David F Bruhn; Tanja Matt; Michael S Scherman; Bernd Meibohm; Erik C Böttger; Anne J Lenaerts; Pavan K Vaddady; Zhong Zheng; Jianjun Qi; Rashid Akbergenov; Sourav Das; Dora B Madhura; Chetan Rathi; Ashit Trivedi; Cristina Villellas; Robin B Lee; Samanthi L Waidyarachchi; Dianqing Sun; Michael R McNeil; Jose A Ainsa; Helena I Boshoff; Mercedes Gonzalez-Juarrero
Journal:  Nat Med       Date:  2014-01-26       Impact factor: 53.440
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.